Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Midatech Pharma (MTP) stocks in Canada

Learn how to easily invest in Midatech Pharma stocks.

Midatech Pharma is a biotechnology business based in the US. Midatech Pharma stocks (MTP.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.87 – a decrease of 5.21% over the previous week. Midatech Pharma employs 18 staff and has a trailing 12-month revenue of around $576,000.

How to buy shares in Midatech Pharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MTP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Midatech Pharma stock price (NASDAQ:MTP)

Use our graph to track the performance of MTP stocks over time.

Midatech Pharma shares at a glance

Information last updated 2022-01-23.
Latest market close$1.00
52-week range$0.89 - $3.83
50-day moving average $1.31
200-day moving average $1.76
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.88

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Midatech Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Midatech Pharma price performance over time

Historical closes compared with the close of $1 from 2022-01-27

1 week (2022-01-21) -5.21%
1 month (2021-12-29) -7.41%
3 months (2021-10-29) -41.18%
6 months (2021-07-29) -46.52%
1 year (2021-01-29) -53.05%
2 years (2020-01-29) 28.21%
3 years (2019-01-29) 727.13%
5 years (2017-01-27) 3.0838

Midatech Pharma financials

Revenue TTM $576,000
Gross profit TTM $-3,985,000
Return on assets TTM -19.06%
Return on equity TTM -190.94%
Profit margin 0%
Book value $0.30
Market capitalisation $14.9 million

TTM: trailing 12 months

Midatech Pharma share dividends

We're not expecting Midatech Pharma to pay a dividend over the next 12 months.

Have Midatech Pharma's shares ever split?

Midatech Pharma's shares were split on a 1:5 basis on 2 March 2020. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Midatech Pharma shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for Midatech Pharma shares which in turn could have impacted Midatech Pharma's share price.

Midatech Pharma share price volatility

Over the last 12 months, Midatech Pharma's shares have ranged in value from as little as $0.89 up to $3.83. A popular way to gauge a stock's volatility is its "beta".

MTP.US volatility(beta: 1.58)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Midatech Pharma's is 1.5846. This would suggest that Midatech Pharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Midatech Pharma overview

Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom. .

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site